The DIG trial showed that digoxin reduced heart-failure (HF)-related hospitalizations, but not overall mortality, in HF patients with ejection fraction (EF) ≤45%. Low serum digoxin concentrations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results